Inactivation of Uaf1 Causes Defective Homologous Recombination and Early Embryonic Lethality in Mice

Por Park, Eunmi, Kim, Jung Min, Primack, Benjamin, Weinstock, David M., Moreau, Lisa A., Parmar, Kalindi, D'Andrea, Alan D.
Publicado em 2013

FANCD2 Activates Transcription of TAp63 and Suppresses Tumorigenesis

Por Park, Eunmi, Kim, Hyungjin, Kim, Jung Min, Primack, Benjamin, Vidal-Cardenas, Sofia, Xu, Ye, Price, Brendan D., Mills, Alea A., D’Andrea, Alan D.
Publicado em 2013

Homologous recombination-deficient tumors are hyper-dependent on POLQ-mediated repair

Por Ceccaldi, Raphael, Liu, Jessica C., Amunugama, Ravindra, Hajdu, Ildiko, Primack, Benjamin, Petalcorin, Mark I.R., O'Connor, Kevin W., Konstantinopoulos, Panagiotis A., Elledge, Stephen J., Boulton, Simon J., Yusufzai, Timur, D'Andrea, Alan D.
Publicado no Nature (2015)

CDK12 INHIBITION REVERSES DE NOVO AND ACQUIRED PARP INHIBITOR RESISTANCE IN BRCA WILD-TYPE AND MUTATED MODELS OF TRIPLE-NEGATIVE BREAST CANCER

Por Johnson, Shawn F., Cruz, Cristina, Greifenberg, Ann Katrin, Dust, Sofia, Stover, Daniel G., Chi, David, Primack, Benjamin, Cao, Shiliang, Bernhardy, Andrea J., Coulson, Rhiannon, Lazaro, Jean-Bernard, Kachupurakkal, Bose, Sun, Heather, Unitt, Christine, Moreau, Lisa A., Sarosiek, Kristopher A., Scaltriti, Maurizio, Juric, Dejan, Baselga, José, Richardson, Andrea L., Rodig, Scott J., D’Andrea, Alan D., Balmaña, Judith, Johnson, Neil, Geyer, Matthias, Serra, Violeta, Lim, Elgene, Shapiro, Geoffrey I.
Publicado no Cell Rep (2016)